107465-03-2CC(Cl)(Cl)C(c1ccc(Cl)cc1)c1ccccc1ClMOTIYCLHZZLHHQ-UHFFFAOYSA-NMitometh is under investigation for the treatment of Adenocarcinoma, Oropharyngeal Neoplasms, Nasopharyngeal Carcinoma, Non-small Cell Lung Cancer, and Stage IV Non-small Cell Lung Cancer, among others. Mitometh has been investigated for the treatment of Lung Neoplasms, Untreated Childhood Medulloblastoma, and Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor.
107465-03-2現在のフィルター条件では反応記録がありません。
読み込み中…
DTXSID80910335